🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 29970R204 (prev. 29970R105 )
- Market Cap
- Micro Cap
- IPO
- 2/5/2021 · $10.00/share
- ADR Ratio
- 1:50
Business: Evaxion Biotech A/S is a clinical-stage AI-immunology™ platform company decoding the human immune system to discover and develop novel immunotherapies to treat cancer and infectious diseases. Based on its proprietary and scalable AI-immunology core technology, Evaxion is developing a broad pipeline of novel product candidates which currently includes three patient-specific cancer immunotherapies, two of which are in Phase I/IIa clinical development.
Company Contact
- CEO
- Lars Staal Wegner
- CFO
- Niels Iversen Møller
- Investor Relations
- EVAX-investor@evaxion-biotech.com